195 related articles for article (PubMed ID: 31004114)
1. A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens.
Kennedy R; Kuvshinov D; Sdrolia A; Kuvshinova E; Hilton K; Crank S; Beavis AW; Green V; Greenman J
Sci Rep; 2019 Apr; 9(1):6327. PubMed ID: 31004114
[TBL] [Abstract][Full Text] [Related]
2. A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform.
Riley A; Green V; Cheah R; McKenzie G; Karsai L; England J; Greenman J
BMC Cancer; 2019 Mar; 19(1):259. PubMed ID: 30902086
[TBL] [Abstract][Full Text] [Related]
3. Analysis of radiation-induced cell death in head and neck squamous cell carcinoma and rat liver maintained in microfluidic devices.
Carr SD; Green VL; Stafford ND; Greenman J
Otolaryngol Head Neck Surg; 2014 Jan; 150(1):73-80. PubMed ID: 24098006
[TBL] [Abstract][Full Text] [Related]
4. A comparison of cell survival and heat shock protein expression after radiation in normal dermal fibroblasts, microvascular endothelial cells, and different head and neck squamous carcinoma cell lines.
Muschter D; Geyer F; Bauer R; Ettl T; Schreml S; Haubner F
Clin Oral Investig; 2018 Jul; 22(6):2251-2262. PubMed ID: 29307045
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
Bhattacharyya S; Sekar V; Majumder B; Mehrotra DG; Banerjee S; Bhowmick AK; Alam N; Mandal GK; Biswas J; Majumder PK; Murmu N
Cell Oncol (Dordr); 2017 Apr; 40(2):145-155. PubMed ID: 28039610
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.
Masunaga S; Ono K; Takahashi A; Ohnishi T; Kinashi Y; Takagaki M
Eur J Cancer; 2002 Mar; 38(5):718-27. PubMed ID: 11916556
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
9. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
Pigorsch SU; Wilkens JJ; Kampfer S; Kehl V; Hapfelmeier A; Schläger C; Bier H; Schwaiger M; Combs SE
Radiat Oncol; 2017 Mar; 12(1):45. PubMed ID: 28249612
[TBL] [Abstract][Full Text] [Related]
10. Personalised organs-on-chips: functional testing for precision medicine.
van den Berg A; Mummery CL; Passier R; van der Meer AD
Lab Chip; 2019 Jan; 19(2):198-205. PubMed ID: 30506070
[TBL] [Abstract][Full Text] [Related]
11. Head and Neck Squamous Cell Carcinoma Biopsies Maintained Ex Vivo on a Perfusion Device Show Gene Changes with Time and Clinically Relevant Doses of Irradiation.
Green V; Baldwin L; England J; Marshall G; Frost L; Moore C; Greenman J
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760543
[TBL] [Abstract][Full Text] [Related]
12. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.
Astolfi M; Péant B; Lateef MA; Rousset N; Kendall-Dupont J; Carmona E; Monet F; Saad F; Provencher D; Mes-Masson AM; Gervais T
Lab Chip; 2016 Jan; 16(2):312-25. PubMed ID: 26659477
[TBL] [Abstract][Full Text] [Related]
13. Development of a Microfluidic Culture Paradigm for Ex Vivo Maintenance of Human Glioblastoma Tissue: A New Glioblastoma Model?
Olubajo F; Achawal S; Greenman J
Transl Oncol; 2020 Jan; 13(1):1-10. PubMed ID: 31726354
[TBL] [Abstract][Full Text] [Related]
14. A microfluidic system for testing the responses of head and neck squamous cell carcinoma tissue biopsies to treatment with chemotherapy drugs.
Hattersley SM; Sylvester DC; Dyer CE; Stafford ND; Haswell SJ; Greenman J
Ann Biomed Eng; 2012 Jun; 40(6):1277-88. PubMed ID: 21997391
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Ahn D; Lee GJ; Sohn JH; Lee JE
Cancer Med; 2020 Dec; 9(24):9256-9265. PubMed ID: 33073917
[TBL] [Abstract][Full Text] [Related]
16. A systematic overview of radiation therapy effects in head and neck cancer.
Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
[TBL] [Abstract][Full Text] [Related]
17. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
18. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
Marcu L; Bezak E
Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent hyperthermic enhancement of tumour growth inhibition by X-ray or carbon-ion beam irradiation.
Takahashi A; Ota I; Tamamoto T; Asakawa I; Nagata Y; Nakagawa H; Kondo N; Ohnishi K; Furusawa Y; Matsumoto H; Ohnishi T
Int J Hyperthermia; 2003; 19(2):145-53. PubMed ID: 12623637
[TBL] [Abstract][Full Text] [Related]
20. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
Heukelom J; Hamming O; Bartelink H; Hoebers F; Giralt J; Herlestam T; Verheij M; van den Brekel M; Vogel W; Slevin N; Deutsch E; Sonke JJ; Lambin P; Rasch C
BMC Cancer; 2013 Feb; 13():84. PubMed ID: 23433435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
